Onconetix (ONCO) Shares Outstanding (2021 - 2026)
Onconetix (ONCO) posted quarterly Shares Outstanding (Entity) of $62853.0 for Q1 2026, up 1370.25% year-over-year from $4275.0 in Q1 2025, and up 235.14% quarter-over-quarter from $18754.0 in Q4 2025.
Onconetix (ONCO) Shares Outstanding (2021 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Shares Outstanding (Entity) for 6 consecutive years, with $62853.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 1370.25% year-over-year to $62853.0; the TTM figure through Mar 2026 stood at $62853.0 (up 1370.25% YoY), while the FY2025 annual figure was $18754.0, up 2803.1% from the prior year.
- Shares Outstanding (Entity) improved to $62853.0 in Q1 2026 per ONCO's latest filing, from $18754.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $62853.0 in Q1 2026 and bottomed at $37.0 in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $7667.3 across 5 years, with a median of $134.0 in 2024.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) grew 25.58% — and 2025, when it soared 10068.08%.
- Onconetix's Shares Outstanding (Entity) stood at $72.0 in 2022, then soared by 40.28% to $101.0 in 2023, then surged by 539.6% to $646.0 in 2024, then surged by 2803.1% to $18754.0 in 2025, then surged by 235.14% to $62853.0 in 2026.
- Business Quant data shows ONCO's Shares Outstanding (Entity) at $62853.0 in Q1 2026, $18754.0 in Q4 2025, and $31216.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | 2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.24 Mn |
| Mar 31, 2026 | 62,853.00 |
| Dec 31, 2025 | 18,754.00 |
| Sep 30, 2025 | 28,109.00 |
| Jun 30, 2025 | 11,353.00 |
| Mar 31, 2025 | 4,275.00 |
| Dec 31, 2024 | 646.00 |
| Sep 30, 2024 | 307.00 |
| Jun 30, 2024 | 131.00 |
| Mar 31, 2024 | 130.00 |
| Dec 31, 2023 | 101.00 |
| Sep 30, 2023 | 103.00 |
| Jun 30, 2023 | 94.00 |
| Mar 31, 2023 | 94.00 |
| Dec 31, 2022 | 72.00 |
| Sep 30, 2022 | 84.00 |
| Jun 30, 2022 | 71.00 |
| Mar 31, 2022 | 37.00 |
| Dec 31, 2021 | 19.00 |
| Sep 30, 2021 | 19.00 |